What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News NFL Biosciences secures €1.2m non-dilutive funding to accelerate Phase 3 development of NFL-101 Find out how NFL Biosciences secured €1.2 million non-dilutive funding to accelerate Phase 3 of NFL-101, a first-in-class botanical smoking cessation drug. byPallavi MadhirajuJuly 22, 2025